Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vibegron long-term extension in men with OAB and BPH
NCT04103450Phase 3Completed
- Sponsor
- Urovant Sciences
- Start
- Sep 2019
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of vibegron in overactive bladder (OAB), sponsored by Urovant Sciences. Started Sep 2019; status: completed.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04103450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04103450.